Latest NewsApr 29, 2025HiFiBiO Therapeutics to Present Preclinical Data for A Novel Immunology Antibody at the 2025 Annual Meeting of the Clinical Immunology Society All Filter By: Year20252024202320222021202020192018201720162015Jan 10, 2022HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB301001Dec 20, 2021FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 ProgramNov 1, 2021HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200301Sep 23, 2021HiFiBiO Therapeutics Contributes to CoVIC-Led Science Publication on SARS-CoV-2 Spike Antibodies Effective Against Variants of ConcernJun 17, 2021FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease< 1 … 5 6 7 8 9 … 17 >
